Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Dr. Sean Pittock discusses the main takeaways from his article on eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder.
7 Loka 20191min
Inflammatory subtype of cerebral amyloid angiopathy
Dr. Aaron Rothstein discusses a less well-known imaging finding on a inflammatory subtype of cerebral amyloid angiopathy.
3 Loka 20191min
McArdle sign in MS
Dr. Eoin Flanagan discusses the McArdle sign in multiple sclerosis.
2 Loka 201959s
Combination therapy with nusinersen and AVXS-101 in SMA type 1
Dr. Emma Ciafaloni discusses the main takeaways from her paper combination therapy with nusinersen and AVXS-101 in SMA type 1.
1 Loka 20192min
Neuroimaging Findings in US Government Personnel With Possible Exposure to Directional Phenomena in Havana, Cuba
Dr. Douglas Smith discusses the main takeaways from his paper, "Neuroimaging Findings in US Government Personnel With Possible Exposure to Directional Phenomena in Havana, Cuba" from JAMA.
30 Syys 20191min
World travel reporting of neurologic care: Thailand
In the first part of a multi-part series, Dan Xia talks about what he learns about neurologic care from his travels around the world, this time from Thailand.
27 Syys 20192min
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
Dr. Mauricio Farez talks about the main points from his practice guidelines paper on vaccine-preventable infections and immunization in multiple sclerosis.
24 Syys 20191min
Drug Pricing Update Part 1
Dr. Steve Pearson gives more takeaways from the second part of his update discussion with Dr. Gordon Smith on drug pricing.
23 Syys 20192min
